4btt: Difference between revisions

No edit summary
No edit summary
 
(3 intermediate revisions by the same user not shown)
Line 1: Line 1:


==factor Xa in complex with the dual thrombin-FXa inhibitor 31.==
==factor Xa in complex with the dual thrombin-FXa inhibitor 31.==
<StructureSection load='4btt' size='340' side='right' caption='[[4btt]], [[Resolution|resolution]] 2.59&Aring;' scene=''>
<StructureSection load='4btt' size='340' side='right'caption='[[4btt]], [[Resolution|resolution]] 2.59&Aring;' scene=''>
== Structural highlights ==
== Structural highlights ==
<table><tr><td colspan='2'>[[4btt]] is a 4 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4BTT OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4BTT FirstGlance]. <br>
<table><tr><td colspan='2'>[[4btt]] is a 4 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4BTT OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4BTT FirstGlance]. <br>
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=VYR:N-[(S)-1-[5-(5-CHLORO-THIOPHEN-2-YL)-ISOXAZOL-3-YLMETHYL]-2-(4-METHOXY-PIPERIDIN-1-YL)-2-OXO-ETHYL]-2-ETHYL-3-(3-OXO-MORPHOLIN-4-YL)-BENZENESULFONAMIDE'>VYR</scene></td></tr>
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.59&#8491;</td></tr>
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4bti|4bti]], [[4btu|4btu]]</td></tr>
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=VYR:N-[(S)-1-[5-(5-CHLORO-THIOPHEN-2-YL)-ISOXAZOL-3-YLMETHYL]-2-(4-METHOXY-PIPERIDIN-1-YL)-2-OXO-ETHYL]-2-ETHYL-3-(3-OXO-MORPHOLIN-4-YL)-BENZENESULFONAMIDE'>VYR</scene></td></tr>
<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Coagulation_factor_Xa Coagulation factor Xa], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.21.6 3.4.21.6] </span></td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4btt FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4btt OCA], [https://pdbe.org/4btt PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4btt RCSB], [https://www.ebi.ac.uk/pdbsum/4btt PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4btt ProSAT]</span></td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4btt FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4btt OCA], [http://pdbe.org/4btt PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4btt RCSB], [http://www.ebi.ac.uk/pdbsum/4btt PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4btt ProSAT]</span></td></tr>
</table>
</table>
== Disease ==
== Disease ==
[[http://www.uniprot.org/uniprot/FA10_HUMAN FA10_HUMAN]] Defects in F10 are the cause of factor X deficiency (FA10D) [MIM:[http://omim.org/entry/227600 227600]]. A hemorrhagic disease with variable presentation. Affected individuals can manifest prolonged nasal and mucosal hemorrhage, menorrhagia, hematuria, and occasionally hemarthrosis. Some patients do not have clinical bleeding diathesis.<ref>PMID:2790181</ref> <ref>PMID:1973167</ref> <ref>PMID:1985698</ref> <ref>PMID:7669671</ref> <ref>PMID:8529633</ref> <ref>PMID:7860069</ref> <ref>PMID:8845463</ref> <ref>PMID:8910490</ref> <ref>PMID:10468877</ref> <ref>PMID:10746568</ref> <ref>PMID:10739379</ref> <ref>PMID:11248282</ref> <ref>PMID:11728527</ref> <ref>PMID:12945883</ref> <ref>PMID:15650540</ref> <ref>PMID:17393015</ref> <ref>PMID:19135706</ref>
[https://www.uniprot.org/uniprot/FA10_HUMAN FA10_HUMAN] Defects in F10 are the cause of factor X deficiency (FA10D) [MIM:[https://omim.org/entry/227600 227600]. A hemorrhagic disease with variable presentation. Affected individuals can manifest prolonged nasal and mucosal hemorrhage, menorrhagia, hematuria, and occasionally hemarthrosis. Some patients do not have clinical bleeding diathesis.<ref>PMID:2790181</ref> <ref>PMID:1973167</ref> <ref>PMID:1985698</ref> <ref>PMID:7669671</ref> <ref>PMID:8529633</ref> <ref>PMID:7860069</ref> <ref>PMID:8845463</ref> <ref>PMID:8910490</ref> <ref>PMID:10468877</ref> <ref>PMID:10746568</ref> <ref>PMID:10739379</ref> <ref>PMID:11248282</ref> <ref>PMID:11728527</ref> <ref>PMID:12945883</ref> <ref>PMID:15650540</ref> <ref>PMID:17393015</ref> <ref>PMID:19135706</ref>  
== Function ==
== Function ==
[[http://www.uniprot.org/uniprot/FA10_HUMAN FA10_HUMAN]] Factor Xa is a vitamin K-dependent glycoprotein that converts prothrombin to thrombin in the presence of factor Va, calcium and phospholipid during blood clotting.  
[https://www.uniprot.org/uniprot/FA10_HUMAN FA10_HUMAN] Factor Xa is a vitamin K-dependent glycoprotein that converts prothrombin to thrombin in the presence of factor Va, calcium and phospholipid during blood clotting.
<div style="background-color:#fffaf0;">
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
== Publication Abstract from PubMed ==
Line 29: Line 28:
__TOC__
__TOC__
</StructureSection>
</StructureSection>
[[Category: Coagulation factor Xa]]
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
[[Category: Alet, N]]
[[Category: Large Structures]]
[[Category: Altenburger, J M]]
[[Category: Alet N]]
[[Category: Barre, G]]
[[Category: Altenburger JM]]
[[Category: Bocskei, Z]]
[[Category: Barre G]]
[[Category: Bono, F]]
[[Category: Bocskei Z]]
[[Category: Briot, C]]
[[Category: Bono F]]
[[Category: Dol, F]]
[[Category: Briot C]]
[[Category: Follmann, M]]
[[Category: Dol F]]
[[Category: Hasbrand, C]]
[[Category: Follmann M]]
[[Category: Herault, J P]]
[[Category: Hasbrand C]]
[[Category: Herbert, J M]]
[[Category: Herault J-P]]
[[Category: Klieber, S]]
[[Category: Herbert J-M]]
[[Category: Lassalle, G]]
[[Category: Klieber S]]
[[Category: Meneyrol, J]]
[[Category: Lassalle G]]
[[Category: Millet, L]]
[[Category: Meneyrol J]]
[[Category: Petit, F]]
[[Category: Millet L]]
[[Category: Rousseaux, T]]
[[Category: Petit F]]
[[Category: Sadoun, F]]
[[Category: Rousseaux T]]
[[Category: Schaeffer, P]]
[[Category: Sadoun F]]
[[Category: Schreuder, H]]
[[Category: Schaeffer P]]
[[Category: Stehlin-Gaon, C]]
[[Category: Schreuder H]]
[[Category: Wehner, V]]
[[Category: Stehlin-Gaon C]]
[[Category: Chlorothiophene p1 fragment]]
[[Category: Wehner V]]
[[Category: Dual inhibitor]]
[[Category: Factor xa inhibitor]]
[[Category: Hydrolase]]
[[Category: Iv antithrombotic]]
[[Category: Microsomes stability]]
[[Category: Oral antithrombotic]]
[[Category: S3 subsite]]
[[Category: Sar107375]]
[[Category: Thrombin inhibitor]]

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA